AI-generated summary
The authors randomized 32 patients with dementia to transcranial low-level laser therapy or a sham laser and assessed cognition with the MMSE and CDR at baseline, week 2 and week 8. They report that MMSE scores improved more in the laser group than in the sham group, while CDR scores did not change meaningfully in either group. The authors suggest laser therapy could be a promising adjunct to pharmacotherapy.
- Participants
- 32
- Who or what was studied
- Patients with dementia
- Limits stated in the abstract
- The abstract reports a small sample of 32 patients and does not state a wavelength or dose for the laser, and the authors describe the findings as suggestive rather than conclusive.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Dementia, Laser, Sham, Trial registration. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.